Skip to main content
. 2019 Jun 21;110(3-4):282–291. doi: 10.1159/000501617

Table 1.

Characteristics of study sample

All (n = 83,592) Corticosteroid use
nonusers (n = 74,591) users (n = 9,001)
Demographics
Age, yearsa 44.2±12.3 44.1±12.3 45.2±12.6
Sex, femalea 49,174 (58.8) 43,512 (58.3) 5,662 (62.9)
Educational attainmenta
 Low 24,752 (29.6) 21,998 (29.5) 2,754 (30.6)
 Middle 32,879 (39.3) 29,491 (39.5) 3,388 (37.6)
 High 24,424 (29.2) 21,747 (29.2) 2,677 (29.7)
 Other 1,537 (1.8) 1,355 (1.8) 182 (2.0)
Use of psychotropic drugsa 7,441 (8.9) 6,331 (8.5) 1,110 (12.3)
High-sensitive CRP, mg/La,b 1.20 (2.20) 1.20 (2.10) 1.50 (2.90)

Lifestyle
Physical activity
 0 days per week 4,071 (4.9) 3,628 (4.9) 443 (4.9)
 1–4 days per week 38,632 (46.2) 34,568 (46.3) 4,064 (45.2)
 ≥5 days per week 40,889 (48.9) 36,395 (48.8) 4,494 (49.9)
Smokinga
 Nonsmoker 38,790 (46.4) 34,428 (46.2) 4,362 (48.5)
 Former smoker 26,098 (31.2) 23,095 (31.0) 3,003 (33.4)
 Current smoker 18,704 (22.4) 17,068 (22.9) 1,636 (18.2)
Alcohol usea
 None 18,490 (22.1) 16,310 (21.9) 2,180 (24.2)
 ≤1 drink/day 41,161 (49.2) 36,701 (49.2) 4,460 (49.6)
 1–2 drinks/day 17,049 (20.4) 15,356 (20.6) 1,693 (18.8)
 >2 drinks/day 6,892 (8.3) 6,224 (8.3) 668 (7.4)

Cardiometabolic features
BMI, kg/m2a 26.1±4.3 26.0±4.3 26.7±4.8
Cardiovascular diseasesa 1,762 (2.1) 1,526 (2.0) 236 (2.6)
 Strokea 555 (0.7) 481 (0.6) 74 (0.8)
 Coronary heart diseasea 1,253 (1.5) 1,084 (1.5) 169 (1.9)

Ruffigural fluency test (executive cognitive functioning)
Unique designsa 81.3±23.3 81.5±23.3 79.9±23.4

MINI (psychiatric disorders)
Mood and/or anxiety disordersa 9,301 (11.1) 8,064 (10.8) 1,237 (13.7)
 Mood disordersa 2,802 (3.4) 2,393 (3.2) 409 (4.5)
 Anxiety disordersa 8,212 (9.8) 7,138 (9.6) 1,074 (11.9)

RAND36 (health-related quality of life)
Physical component summary scorea 52.9±7.5 53.3±7.2 50.3±9.0

All values are depicted as median (interquartile range), mean ± SD, or numbers (percentage). BMI, body mass index; CRP, C-reactive protein.

a

Significant crude differences between nonusers and users

b

data on high-sensitive CRP were available in 45,395 participants including 40,695 nonusers and 4,700 users.